Reduced radiotherapy by combining chemotherapy with intrathecal administration of methotrexate for pediatric patients with intracranial germ cell tumor
semanticscholar(2021)
摘要
Background: Treatment of intracranial germ cell tumors (GCTs) involves
radiation therapy to the whole ventricle or the whole neuroaxis, but
late sequelae are a concern. Therefore, an alternative modality is
needed to reduce the overreliance on radiation therapy. Intrathecal
methotrexate (IT-MTX) was examined as a partial alternative to
radiotherapy. Procedure: Low-risk (LR) patients (germinoma) were treated
with four cycles of cisplatin, etoposide, and IT-MTX, while
intermediate-risk (IR) (human chorionic gonadotropin [HCG]-producing
germinoma) and high-risk (HR) (non-germinomatous GCT) patients were
treated with five cycles of cisplatin, etoposide, cyclophosphamide, and
IT-MTX. Local irradiation of 24 Gy was performed for the LR and IR
patients, while irradiation with 51.2 Gy was performed for the HR cases.
For patients with multifocal diseases and/or tumors extending to the 3rd
ventricle, whole ventricle irradiation was performed. Results: A total
of 57 patients were enrolled, of which three withdrew consent. Thus, 54
patients were included in the outcome analysis. The 5-year
progression-free survival and overall survival were 92.0% (standard
error 4.4%) and 100%, respectively, for 28 LR and 10 IR patients
(median follow-up: 63 months), and 86.7% (8.8%) and 93.3% (6.4%)
(median follow-up: 67 months), respectively, for 16 HR patients. The
major toxicity was hematological, and most patients experienced grade 4.
Conclusion: The toxicity of chemotherapy containing IT-MTX was limited,
and the results suggested that this regimen could reduce the need for
radiotherapy.
更多查看译文
关键词
intracranial germ cell tumor,chemotherapy,radiotherapy,methotrexate,germ cell tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要